Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Ultimately, by early November 2025 Metsera accepted Pfizers sweetened offer: $86.25 per share ($10.0 billion total) comprising $65.60 cash and up to $20.65 in contingent value rights (CVRs) ( [6] ) ( [7] )
If you are experiencing persistent discomfort, it is rarely the medication itself, but rather how your body is adapting to its new metabolic state
This format allows researchers to store the peptide efficiently before reconstitution according to established laboratory protocols
Patients should continue evidence-based lipid-lowering therapy as recommended by NICE guidelines whilst considering GLP-1 therapy for its licensed indications
US$ 26.61
US$ 20.23
US$ 21.27
US$ 20.69
US$ 28.41
US$ 28.88
